Globus Medical (GMED) Debt to Equity (2024)

Globus Medical (GMED) reported Debt to Equity of $0.11 for Q4 2024, down 1.2% quarter-over-quarter from $0.11 in Q3 2024.

Globus Medical (GMED) Debt to Equity (2024) Analysis & Trends

Globus Medical has reported Debt to Equity for 1 years, with the latest figure at $0.11 in Q4 2024.

  • For the quarter ending Q4 2024, Debt to Equity changed N/A year-over-year to $0.11; the trailing twelve-month figure through Dec 2024 stood at $0.11 (changed N/A YoY), and the FY2024 full-year result was $0.11, changed N/A from the prior year.
  • Debt to Equity for Q4 2024 stood at $0.11, down from $0.11 in the prior quarter.
  • The five-year high for Debt to Equity was $0.11 in Q2 2024, with the low at $0.11 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.65
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.64
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.57
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.71
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.95
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.27
10 Globus Medical 10.71 Bn 10.08 Bn 525.79 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 0.11
Sep 30, 2024 0.11
Jun 30, 2024 0.11
Mar 31, 2024 0.11